LAB
Standard Biotools Inc
0.7399$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.0% | +33.0% | -25.8% | +0.1% | +2.5% | +5.5% | -4.2% | +40.0% | -76.9% | +9.1% | -9.6% | – | |
| – | +2.6% | +2.7% | +88.6% | -12.0% | +26.2% | +20.6% | -40.4% | +40.3% | -23.8% | +53.6% | -54.1% | – | |
| – | -195.2% | – | – | – | – | -279.8% | – | – | – | – | – | – | |
| – | -91.4% | +901.3% | +148.0% | +16.4% | +50.0% | +49.4% | -62.7% | -53.0% | -46.3% | +19.7% | -39.6% | – | |
| – | -73.7% | – | -84.2% | -161.5% | – | -43.2% | +88.1% | -124.3% | +59.9% | – | -92.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -56.4% | +6,260.9% | +166.0% | -99.8% | -35.7% | +2.2% | +334.8% | -44.0% | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -13.8% | +1,867.4% | +43.7% | -100.0% | +2,725,900.0% | -99.9% | – | -203.7% | – | -106.5% | +245.0% | – | |
| – | – | – | -107.3% | – | – | – | – | -477.6% | – | – | -97.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.